DOI: 10.1111/bju.13954 , , PMID: 28688143 Issn Print: 1464-4096 Publication Date: 2017/12/01 Print Facebook Twitter LinkedIn Email First‐line vascular endothelial growth factor inhibitors for advanced renal cell carcinoma and the impact of new agents entering the treatment paradigm Rohit Jain; Saby George + Author Information Author Information: Roswell Park Institute Checking for direct PDF access through Ovid View on Journal Site Abstract Abstract unavailable for this article.